Skip to main content
×
Home

TRANSFERABILITY OF HEALTH TECHNOLOGY ASSESSMENT REPORTS IN LATIN AMERICA: AN EXPLORATORY SURVEY OF RESEARCHERS AND DECISION MAKERS

  • Andres Pichon-Riviere (a1), Federico Augustovski (a2), Sebastián García Martí (a3), Sean D. Sullivan (a4) and Michael Drummond (a5)...
Abstract

Introduction: HTA agencies, especially in developing countries, are under resourced and unable to conduct the desired amount of assessments. Adapting HTA reports (HTAs) from other jurisdictions is an alternative for saving resources.

Objectives: To explore HTA transferability experiences in Latin-America and Caribbean (LAC): are decision makers (DMs) using HTAs from other jurisdictions? Are researchers adapting HTAs when developing local reports? How useful is the information found in HTAs from other jurisdictions?

Methods: Web-based survey sent to 13031 HTA researchers and DMs.

Results: We received 671 responses from 19 countries. DMs reported using HTAs from other jurisdictions to guide decisions in the majority of the situations: 52.6 percent HTAs from outside LAC (e.g., Europe), 23.1 percent from other LAC countries, and only 24.3 percent HTAs from their own countries. 63 percent of researchers reported using HTAs from other jurisdictions. Usefulness scored significantly higher for HTAs from other jurisdictions as compared to local HTAs (7.1 versus 6.0 in a 1–10 scale; p < .01). Both DMs and researchers considered the information regarding safety and effectiveness more applicable than the information on social aspects, or economic evaluation. Barriers that limit transferability had significantly different scores for HTAs from other LAC countries as compared to those from regions outside LAC (i.e., poor methodological quality 6.7 versus 5.3, different epidemiological context 6.0 versus 7.4; all p < .01).

Conclusions: HTAs from outside the region are commonly used. However, DMs and researchers agreed that HTAs from LAC had the greatest potential for transferability, provided that barriers such as poor methodological quality could be overcome.

Copyright
References
Hide All
1.Augustovski F, Iglesias C, Manca A, et al. Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region. Pharmacoeconomics. 2009;27:919929.
2.Augustovski F, Bastardo Y, Caso A, et al. Pharmacoeconomics and outcomes research in Latin America: Argentina, Brazil, Chile, Colombia, and Mexico. ISPOR Connections; 2008.
3.Banta D. Health technology assessment in Latin America and the Caribbean. Int J Technol Assess Health Care. 2009;25 (Suppl 1):253254.
4.Barbieri M, Drummond M, Rutten F, et al. ISPOR Good Research Practices Economic Data Transferability Task Force. What do international pharmacoeconomic guidelines say about economic data transferability? Value Health. 2010;13:10281037.
5.Bertozzi S, Valencia Mendoza A, Hernández Garduño C, et al. Guía Para la Conducción de Estudios de Evaluación Económica Para la Actualización del Cuadro Básico de Insumos del Sector Salud en México. Cuernavace, Mexico: Instituto Nacional de Salud Pública; 2008.
6.Boulenger S, Nixon J, Drummond M, et al. Can economic evaluations be made more transferable? Eur J Health Econ. 2005;6:334346.
7.Carrasquilla Gutierrez G. Guía Metodológica para la Elaboración de Guías de Práctica Clínica Basadas en la Evidencia, de Evaluaciones Económicas y de Evaluación del Impacto de la Implementación de las Guías en el POS y en la Unidad de Pago por Capitación del Sistema General de Seguridad Social en Salud Colombiano. Colombia: Ministerio de la Protección Social Colciencias; 2008. www.pos.gov.co/Documents/GUIA%20METODOL%C3%93GICA%2023%2011%2009-1.pdf.
8.Chase D, Rosten C, Turner S, Hicks N, Milne R. Development of a toolkit and glossary to aid in the adaptation of health technology assessment (HTA) reports for use in different contexts. Health Technol Assess. 2009;13:1142, iii.
9.Drummond M, Barbieri M, Cook J, et al. Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. Value Health. 2009;12:409418.
10.Essers BA, Seferina SC, Tjan-Heijnen VC, et al. Transferability of model-based economic evaluations: The case of trastuzumab for the adjuvant treatment of HER2-positive early breast cancer in the Netherlands. Value Health. 2010;13:375380.
11.Estudos de avaliaçao econômica de tecnologias em saúde. Normas e Manuais Técnicos. Brasil: Ministerio da Saúde; 2009. http://bvsms.saude.gov.br/bvs/publicacoes/avaliacao_economica_tecnologias_saude_2009.pdf.
12.Gálvez González A. Guía Metodológica Para la Evaluación Económica en Salud: Cuba 2003. Cuba: Ministerio de Salud Pública, Escuela Nacional de Salud Pública; 2003. www.ispor.org/peguidelines/source/MethodologicalGuidelinesforHealthEconomicEvaluationsinCuba.pdf.
13.Goeree R, Burke N, O'Reilly D, et al. Transferability of economic evaluations: Approaches and factors to consider when using results from one geographic area for another. Curr Med Res Opin. 2007;23:671682.
14.Guía Para la Elaboración de Informes de Evaluación de Tecnologías Sanitarias. Mercosur (2008) www.saludinvestiga.org.ar/pdf/resoluciones/Res-52-08_ES_GuiaElaboInfTecnoSanit.pdf.
15.Iglesias CP, Drummond MF, Rovira J. Health-care decision-making processes in Latin America: Problems and prospects for the use of economic evaluation. Int J Technol Assess Health Care. 2005;21:114.
16.INAHTA: International Network of Agencies for Health Technology Assessment (INAHTA). http://www.inahta.org (accessed March 5, 2011).
17.Neto G. Utilizaçao de diretrizes nacionais e internacionais para execuçao da avaliaçao de tecnologias em saúde. In: Nita M, ed. Avaliaçao de Tecnologias em Saúde. Artmed, Porto Alegre, Brazil; 2010:506529.
18.Nixon J, Rice S, Drummond M, et al. Guidelines for completing the EURONHEED transferability information checklists. Eur J Health Econ. 2009;10:157165.
19.Pichon-Riviere A, Augustovski F, Rubinstein A, et al. Health technology assessment for resource allocation decisions: Are key principles relevant for Latin America? Int J Technol Assess Health Care. 2010;26:421427.
20.Sculpher MJ, Pang FS, Manca A, et al. Generalisability in economic evaluations studies in health care: A review and case studies. Health Technol Assess. 2004;8:iii-iv, 1192.
21.Singer ME. Cost-effectiveness analysis: Developing nations left behind. Pharmacoeconomics. 2008;26:359561.
22.Turner S, Chase DL, Milne R, et al. European network for Health Technology Assessment (EUnetHTA). The health technology assessment adaptation toolkit: Description and use. Int J Technol Assess Health Care. 2009;25 (Suppl 2):3741.
23.Turner S, Chase DL, Milne R, et al. The adaptation of health technology assessment reports: Identification of the need for, and development of, a toolkit to aid the process. Int J Technol Assess Health Care. 2009;25 (Suppl 2):2836.
24.Urdahl H, Manca A, Sculpher MJ. Assessing generalisability in model-based economic evaluation studies: A structured review in osteoporosis. Pharmacoeconomics. 2006;24:11811197.
25.Welte R, Feenstra T, Jager H, Leidl R. A decision chart for assessing and improving the transferability of economic evaluation results between countries. Pharmacoeconomics. 2004;22:857876.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Journal of Technology Assessment in Health Care
  • ISSN: 0266-4623
  • EISSN: 1471-6348
  • URL: /core/journals/international-journal-of-technology-assessment-in-health-care
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 4
Total number of PDF views: 44 *
Loading metrics...

Abstract views

Total abstract views: 205 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 17th November 2017. This data will be updated every 24 hours.